✦ LIBER ✦

Combination of α-interferon with lamivudine reduces viral breakthrough during long-term therapy

✍ Scribed by MYOUNG KUK JANG; YOUNG-HWA CHUNG; MIN HEE CHOI; JEONG A KIM; SOO HYUNG RYU; JUNG WOO SHIN; IN SOOK KIM; NEUNG HWA PARK; HAN CHU LEE; YUNG SANG LEE; DONG JIN SUH

Book ID: 108949932
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 115 KB
Volume: 19
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2004.03464.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon for treatment of breakthrough

Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy

✍ Fumitaka Suzuki; Akihito Tsubota; Norio Akuta; Takashi Someya; Masahiro Kobayash 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 265 KB

Clinical course of patients with chronic

Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment

✍ Tatsuya Ide; Ryukichi Kumashiro; Reiichiro Kuwahara; Hiroyuki Koga; Yuriko Koga; 📂 Article 📅 2005 🏛 Springer Japan 🌐 English ⚖ 148 KB

Association of core promoter mutations w

Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy

✍ Syed Naqui Kazim; Ranjit Chauhan; Bhudev Chandra Das; Shiv Kumar Sarin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

Interferon-α therapy combined with nonst

Interferon-α therapy combined with nonsteroid antiinflammatory drugs for treatment of chronic viral hepatitis?

✍ Pietro Andreone; Carmela Cursaro; Giovanni Gasbarrini 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

Genetic variability of hepatitis C virus

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon–ribavirin therapy

✍ I. Vuillermoz; E. Khattab; E. Sablon; I. Ottevaere; D. Durantel; C. Vieux; C. Tr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

## Abstract Little is known about hepatitis C virus (HCV) breakthrough during antiviral therapy, although it would help in understanding HCV resistance to current antiviral treatments. To analyse the implication of virological factors and the vigour of humoral immune responses in this phenomenon, w

Precore stop codon mutation of hepatitis

Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy

✍ JUNG WOO SHIN; YOUNG-HWA CHUNG; MIN HEE CHOI; JEONG A KIM; SOO HYUNG RYU; MYOUNG 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB